Skip to Main Content

Paper Details

Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations.
Genome Med
1
2022
APOB gene, APOB genes, CVD, Dyslipidemia, GTF3C5, LDL cholesterol, LDLC, LIPC, LIPC and APOB genes, MARCHF10, PAVs, PCSK9 gene, RBM47, RBM47 gene, RYR3, TRMT5, Thr405Met, apolipoprotein, apolipoprotein B, apolipoprotein C-III, cardiovascular disease, cholesterol, diabetes, genetic disorders, hypercholesterolemia, non-HDL cholesterol, p.Ala496-Ala502 deletion, protein-altering variants, rs113298164, serum apolipoprotein A1, triglyceride, type 1 diabetes
Author NameAffiliation
Aarno PalotieInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Aarno PalotieThe Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard
Aarno PalotieMassachusetts General Hospital
Carol ForsblomFolkhalsan Research Center
Carol ForsblomUniversity of Helsinki and Helsinki University Hospital
Carol ForsblomResearch Program for Clinical and Molecular Metabolism, University of Helsinki
Per-Henrik GroopFolkhalsan Research Center
Per-Henrik GroopUniversity of Helsinki and Helsinki University Hospital
Per-Henrik GroopResearch Program for Clinical and Molecular Metabolism, University of Helsinki
Per-Henrik GroopCentral Clinical School, Monash University
  • 1 - 10

Datasets

Release 1.2